New Evidence of Link Between Zika and Guillain-Barré

Share this content:
New Evidence of Link Between Zika and Guillain-Barré
New Evidence of Link Between Zika and Guillain-Barré

FRIDAY, May 6, 2016 (HealthDay News) -- There is new evidence that Zika may cause Guillain-Barré syndrome, according to a U.S. Centers for Disease Control and Prevention study released Thursday.

Researchers looked at 41 people in Brazil who developed the condition and found that nearly 90 percent of them had earlier suffered Zika-like symptoms, the Associated Press reported. However, the study authors noted that this was a small study and they don't yet have blood test results that would show whether the patients were infected with Zika before developing Guillain-Barré. Those results are expected in about a month.

There has been a sharp increase in the number of people in Brazil with Guillain-Barré since the Zika outbreak began, the AP reported. Scientists believe the body produces antibodies to combat a Zika infection and when the initial Zika symptoms subside, the antibodies attack the peripheral nerves, the AP reported.

A study published earlier this year found Zika antibodies in nearly all people who developed Guillain-Barré during a Zika outbreak in French Polynesia in 2013 and 2014.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Doctors Urged to Speak With Patients About Firearms

Doctors Urged to Speak With Patients About Firearms

Making a public commitment is encouraged as a positive action that physicians can take

Machine Learning Model Predicts Risk of Upgrade to Breast CA

Machine Learning Model Predicts Risk of Upgrade to ...

Model can predict risk of upgrade of high-risk breast lesions to cancer using traditional, text features

Glycemic Control Up With Oral Semaglutide in Type 2 Diabetes

Glycemic Control Up With Oral Semaglutide in Type ...

Phase 3 studies next to assess longer-term/clinical outcomes, safety

is free, fast, and customized just for you!

Already a member?

Sign In Now »